FI905107A0 - Väsentligen renat sulfatas, förfarande för framställning av detta och en Streptomyces-stam producerande detta - Google Patents

Väsentligen renat sulfatas, förfarande för framställning av detta och en Streptomyces-stam producerande detta

Info

Publication number
FI905107A0
FI905107A0 FI905107A FI905107A FI905107A0 FI 905107 A0 FI905107 A0 FI 905107A0 FI 905107 A FI905107 A FI 905107A FI 905107 A FI905107 A FI 905107A FI 905107 A0 FI905107 A0 FI 905107A0
Authority
FI
Finland
Prior art keywords
making
substantially purified
strain producing
streptomyces strain
sulfatase
Prior art date
Application number
FI905107A
Other languages
English (en)
Finnish (fi)
Other versions
FI94362C (sv
FI94362B (sv
Inventor
Yosuke Sawada
Tomokazu Ueki
Satoshi Yamamoto
Koji Tomita
Yasuo Fukagawa
Toshikazu Oki
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI905107A0 publication Critical patent/FI905107A0/sv
Application granted granted Critical
Publication of FI94362B publication Critical patent/FI94362B/sv
Publication of FI94362C publication Critical patent/FI94362C/sv

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Valve Device For Special Equipments (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
FI905107A 1989-10-20 1990-10-17 Väsentligen renat sulfatas, förfarande för framställning av detta och en Streptomyces-stam producerande detta FI94362C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42437689A 1989-10-20 1989-10-20
US42437689 1989-10-20

Publications (3)

Publication Number Publication Date
FI905107A0 true FI905107A0 (sv) 1990-10-17
FI94362B FI94362B (sv) 1995-05-15
FI94362C FI94362C (sv) 1995-08-25

Family

ID=23682406

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905107A FI94362C (sv) 1989-10-20 1990-10-17 Väsentligen renat sulfatas, förfarande för framställning av detta och en Streptomyces-stam producerande detta

Country Status (14)

Country Link
EP (1) EP0423818B1 (sv)
JP (1) JP3097035B2 (sv)
KR (1) KR0144351B1 (sv)
AT (1) ATE162217T1 (sv)
AU (1) AU638283B2 (sv)
CA (1) CA2027977C (sv)
DE (1) DE69031932T2 (sv)
DK (1) DK0423818T3 (sv)
ES (1) ES2111526T3 (sv)
FI (1) FI94362C (sv)
GR (1) GR3026042T3 (sv)
IE (1) IE903767A1 (sv)
PT (1) PT95625B (sv)
ZA (1) ZA908408B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0649330U (ja) * 1992-12-16 1994-07-05 オート化学工業株式会社 流動性物質の貯蔵用容器
GB9323429D0 (en) * 1993-11-12 1994-01-05 Wellcome Found Therapy
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
WO1997021818A1 (fr) * 1995-12-14 1997-06-19 Kyoto Daiichi Kagaku Co., Ltd. Nouvelle oxydase d'acide amine fructosyle provenant d'un champignon du genre penicillium
DE10155764A1 (de) * 2001-11-14 2003-05-28 Degussa Neue Sulfatasen und ihre Verwendung
JP4606712B2 (ja) 2003-01-08 2011-01-05 マサチューセッツ インスティテュート オブ テクノロジー ２−ｏスルファターゼ組成物および関連の方法
WO2008085912A1 (en) 2007-01-05 2008-07-17 Massachusetts Institute Of Technology Compositions of and methods of using sulfatases from flavobacterium heparinum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1262565A (fr) * 1956-05-16 1961-06-05 Procédé de fabrication de produits agricoles par fermentation et produits conformes à ceux ainsi obtenus
NZ225599A (en) * 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells

Also Published As

Publication number Publication date
DE69031932D1 (de) 1998-02-19
GR3026042T3 (en) 1998-04-30
DE69031932T2 (de) 1998-08-27
KR0144351B1 (ko) 1998-07-01
ES2111526T3 (es) 1998-03-16
KR910008131A (ko) 1991-05-30
CA2027977C (en) 2000-01-18
CA2027977A1 (en) 1992-04-19
AU638283B2 (en) 1993-06-24
EP0423818B1 (en) 1998-01-14
ATE162217T1 (de) 1998-01-15
IE903767A1 (en) 1991-04-24
ZA908408B (en) 1992-06-24
FI94362C (sv) 1995-08-25
AU6470890A (en) 1991-04-26
JP3097035B2 (ja) 2000-10-10
FI94362B (sv) 1995-05-15
PT95625B (pt) 1997-08-29
EP0423818A1 (en) 1991-04-24
JPH03155781A (ja) 1991-07-03
DK0423818T3 (da) 1998-09-07
PT95625A (pt) 1991-09-13

Similar Documents

Publication Publication Date Title
SE9301677D0 (sv) Syntesmetod
WO1994021656A3 (en) Novel phospholipid-saccharide conjugates
NZ334828A (en) Contains no O-acetyl groups detectable by NMR and binds to antibodies to S.aureus further conjugated with Pseudomonas aeruginosa exotoxin A as an immunocarrier to detect S.aureus infection
GR3025753T3 (en) Rapamycin assay
FR2734484B1 (fr) Composition vaccinale liquide et procede de fabrication
CA2173822A1 (en) Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli
FI925988A0 (fi) Foerfarande foer framstaellning av b-laktamer
FI905107A0 (sv) Väsentligen renat sulfatas, förfarande för framställning av detta och en Streptomyces-stam producerande detta
ES2131066T3 (es) Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
EP0301522A3 (en) Process for producton of isomaltulose
NO175134C (no) Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav
PL286898A1 (en) Method of obtaining a conjugated vaccine against streptococcus of b group, method of obtaining a recombined molecule and method of obtaining a protein of atreptococcus o b group
NO163574C (no) Fremgangsmaate for fremstilling av antitumor-antibiotika (ll-e33288 kompleks) ved fermentering av micromonospora echinospora ssp. calichensis nrrl 1539 og nrrl 15975.
MY103552A (en) Saccharide derivatives
EP0601318A3 (de) Verfahren zur Herstellung von Konjugaten aus einem spezifischen Bindungspartner und einem kohlenhydrathaltigen Protein.
NO20003890D0 (no) Glykosidering av 4,5-epoksymorfinan-6-oler
DE3888924D1 (de) Monoklonale Antikörper gegen Anthracycline.
BG100779A (en) Derivatives of 12.13-epoxytylosin and methods for their preparation
PT774119E (pt) Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo
UA18246A (uk) Спосіб одержаhhя 4'-дезокси-13(s)-дигідро-4'-йододоксорубіциhу
AU665546B2 (en) Conjugates for treating gastrointestinal tumours

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BRISTOL-MYERS SQUIBB COMPANY